Search

Displaying results 3661 - 3670 of 4860 in total
  1. Drug

    Prademagene zamikeracel

    go.drugbank.com/drugs/DB17895
    ApprovedInvestigational

    [L53013] It was granted an Orphan Drug designation by the EMA.[A273833]

  2. Drug

    Bromopride

    go.drugbank.com/drugs/DB09018
    Investigational

    It is unavailable in America or the United Kingdom.

  3. Drug

    Beraprost

    go.drugbank.com/drugs/DB05229
    Investigational

    It is also being studied for use in avoiding reperfusion injury.

  4. Drug

    Reposal

    go.drugbank.com/drugs/DB13805
    Experimental

    It was used primarily in the treatment of insomnia.

  5. Drug

    ENTR-601-44

    go.drugbank.com/drugs/DB17836
    Investigational

    Developed by Entrada Therapeutics, it was investigated for the treatment of Duchenne muscular dystrophy.[L46641]

  6. Drug

    PAS-004

    go.drugbank.com/drugs/DB18611
    Investigational

    It is being investigated for the treatment of neurofibromatosis 1 and Noonan syndrome.

  7. Drug

    Unasnemab

    go.drugbank.com/drugs/DB18837
    Investigational

    Unasnemab is under investigation in clinical trial NCT04683848 (Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury).

  8. Drug

    NGX267

    go.drugbank.com/drugs/DB05152
    Investigational

    It is developed for the treatment of Alzheimer’s disease and has shown the potential to both reduce symptoms and slow disease progression.

  9. Drug

    CPD 923

    go.drugbank.com/drugs/DB05856
    Experimental

    It shows efficacy in vivo studies, as well as a favourable pre-clinical tolerability profile.

  10. Drug

    PA-1050040

    go.drugbank.com/drugs/DB06039
    Experimental

    It inhibits virus replication by the same mechanism of action as BVM.